Cargando…

Complete recovery from COVID-19 of a kidney-pancreas transplant recipient: potential benefit from everolimus?

We present a kidney-pancreas transplant recipient who achieved complete recovery from COVID-19. A 45-year-old patient with T3 paraplegia underwent kidney-pancreas transplantation 18 years ago, followed by a subsequent kidney transplant 9 years ago, and presented with fever, hypoxia and hypotension a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heron, Vanessa C, Bach, Cindy-Anne T, Holmes, Natasha E, Whitlam, John B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802699/ https://www.ncbi.nlm.nih.gov/pubmed/33431539 http://dx.doi.org/10.1136/bcr-2020-238413

Ejemplares similares

Introduction of everolimus in kidney transplant recipients at a late posttransplant stage
por: Uchida, Junji, et al.
Publicado: (2018)

Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant recipients
por: Pacheco, Larissa Sgaria, et al.
Publicado: (2018)

Incremental Value of the Pancreas Allograft to the Survival of Simultaneous Pancreas-Kidney Transplant Recipients
por: Salvalaggio, Paolo R., et al.
Publicado: (2009)

Everolimus induced pneumonitis in a lung transplant recipient
por: Arunachalam, Ambalavanan, et al.
Publicado: (2018)

Analysis of Individual Components of Frailty in Simultaneous Pancreas and Kidney, and Solitary Pancreas Transplant Recipients
por: Parajuli, Sandesh, et al.
Publicado: (2023)

Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus
por: Menghi, Viola, et al.
Publicado: (2016)

Everolimus-associated alveolar hemorrage relapse after drug discontinuation in a kidney transplant recipient
por: Busutti, Marco, et al.
Publicado: (2022)

Fatal Outcome in a Kidney-Pancreas Transplant Recipient With COVID-19
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020)

Transfusion-Dependent Anemia in a Simultaneous Pancreas and Kidney Transplant Recipient
por: Gopal, Jeevan Prakash, et al.
Publicado: (2020)

Favorable Outcomes in Older Recipients Receiving Simultaneous Pancreas Kidney Transplantation
por: Budhiraja, Pooja, et al.
Publicado: (2022)

Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy
por: Larsson, Pierre, et al.
Publicado: (2023)

Influence of Intraoperative Hemodynamic Parameters on Outcome in Simultaneous Pancreas–Kidney Transplant Recipients
por: Sucher, Robert, et al.
Publicado: (2022)

Geographic Distribution of Cytomegalovirus Serology in Kidney and Pancreas Transplant Recipients in the United States
por: Jorgenson, Margaret R., et al.
Publicado: (2021)

Immune Profiling of Peripheral Blood Mononuclear Cells at Pancreas Acute Rejection Episodes in Kidney-Pancreas Transplant Recipients
por: Rovira, Jordi, et al.
Publicado: (2022)

Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
por: Krzyżowska, Kinga, et al.
Publicado: (2018)

Efficacy and Safety of Low-Dose Everolimus as Maintenance Immunosuppression in Cardiac Transplant Recipients
por: Fuchs, Uwe, et al.
Publicado: (2012)

Everolimus and papillomavirus lesions in female renal transplant recipient: A case report
por: Simundic, T., et al.
Publicado: (2018)

1383. Everolimus is Associated with an Increased Risk of Tuberculosis in Solid-Organ Transplant Recipients
por: Sun, Hsin-Yun, et al.
Publicado: (2019)

Gadolinium-Induced Acute Graft Pancreatitis in a Simultaneous Pancreas-Kidney Transplant Recipient
por: Lee, Chiang Sheng, et al.
Publicado: (2022)

Factors associated with pulmonary infection in kidney and kidney-pancreas transplant recipients: a case-control study
por: de Faria, Leonardo Meira, et al.
Publicado: (2023)

Transfer of Everolimus into Colostrum of a Kidney Transplant Mother
por: Kociszewska-Najman, Bożena, et al.
Publicado: (2017)

Patient, kidney, and pancreas survival in pancreas after kidney transplantation versus simultaneous pancreas and kidney transplantation: meta-analysis
por: Xue, Wenrui, et al.
Publicado: (2022)

Choices in kidney transplantation in type 1 diabetes: Are there skeletal benefits of the endocrine pancreas?
por: Scialla, Julia J.
Publicado: (2013)

Pancreas grafts for transplantation from donors with hypertension: an analysis of the scientific registry of transplant recipients database
por: Hu, Zhen-Hua, et al.
Publicado: (2018)

Everolimus‐facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2‐year results from the subgroup analysis of the TRANSFORM study
por: Watarai, Yoshihiko, et al.
Publicado: (2021)

Excess Mortality in Kidney and Kidney-Pancreas Transplant Recipients in the COVID-19 Pandemic in Portugal—A Cohort Study
por: Coimbra, Miguel T., et al.
Publicado: (2023)

Donor Kidney Recovery Methods and the Incidence of Lymphatic Complications in Kidney Transplant Recipients
por: Saidi, R. F., et al.
Publicado: (2010)

Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients
por: Bremer, Sebastian C. B., et al.
Publicado: (2018)

Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
por: Bergh, Niklas, et al.
Publicado: (2020)

Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
por: Zwart, Tom C., et al.
Publicado: (2020)

Risk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas–Kidney Transplants
por: Vendrame, F., et al.
Publicado: (2015)

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients
por: Bank, Jonna R., et al.
Publicado: (2016)

Chimney-Patch Arterial Graft in Kidney or Pancreas Transplantation for Recipients with Heavily Calcified Iliac Arteries
por: Nezakatgoo, Nosratollah, et al.
Publicado: (2019)

Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient
por: Westhoff, Timm H., et al.
Publicado: (2020)

A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients
por: Chadban, Steven J, et al.
Publicado: (2014)

Mycobacterium chelonae Skin Infection in Kidney-Pancreas Recipient
por: Stelzmueller, Ingrid, et al.
Publicado: (2005)

Results from an International Survey of Donor and Recipient Eligibility for Solid Organ Pancreas Transplantation
por: Ling, Jonathan E.H., et al.
Publicado: (2021)

Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients
por: Bachmann, Friederike, et al.
Publicado: (2022)

Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR)
por: Brakemeier, Susanne, et al.
Publicado: (2019)

Suppression of Allograft Fibrosis by Regulation of Mammalian Target of Rapamycin-Related Protein Expression in Kidney-Transplanted Recipients Treated with Everolimus and Reduced Tacrolimus
por: Nishioka, Shun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7nlicubh13p6s7nl81ditsie9e